Stock LLM Wiki

260610_800V延後_ms_800v-dc-delay

更新 2026-06-11

PDF 原檔:260610_800V延後_ms_800v-dc-delay_original.pdf

原始內容

Cainbit to ouu vue eyurpiten leaumess

Asia Summer School 2026

M June 10, 2026 04:13 AM GMT

Greater China Technology Hardware | Asia Pacific

Power Solutions - Our Thoughts on Rumored 800V DC Delay Impact Foundation for safe and reliable deployment Accelerates deployment readiness

VIDIA

STC

On June 9, SemiAnalysis reported that Nvidia's (covered by Joseph Moore) planned large-scale shipments of native 800V DC power architecture have been pushed back to 2028, later than market expectations, while +-400V remains on schedule for hyperscaler's ASIC deployments. Nvidia has reportedly denied the reports.

Genese. Alricia

Our take: This news is contrary to our supply chain checks at Computex. As we stated in our Computex read-through note, NVDA at GTC Taipei indicated 800 VDC developments are ongoing with 800 VDC power rack being ready for mass production in 3Q26. +-400 VDC development has been redirected to 800 VDC focus across various hyperscalers. ( Exhibit 1 ).

We also note Delta will likely be the first vendor to mass produce 800 VDC standalone power racks in 4Q26 to one of major hyperscalers in the US. We understand the initial shipment volume won't be enormous and it will take some time for 800 VDC protection device development and industrial safety standards to be defined by UL and major regulations. However, 800 VDC developments remains intact, in our view.

Exhibit 1 : 800 VDC equipment readiness

260610_800V延後_ms_800v-dc-delay_001

Source: Nvidia, Morgan Stanley Research.

Morgan Stanley Taiwan Limited+

Sharon Shih

Equity Analyst Sharon.Shih@morganstanley.com

Samantha Chen

Research Associate

Samantha.Chen@morganstanley.com

Update

+886 2 2730-2865

+886 2 2730-2876

260610_800V延後_ms_800v-dc-delay_002

Greater China Technology Hardware

Asia Pacific Industry View

In-Line

Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.

For analyst certification and other important disclosures, refer to the Disclosure Section, located at the end of this report.

+= Analysts employed by non-U.S. affiliates are not registered with FINRA, may not be associated persons of the member and may not be subject to FINRA restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.

M

Disclosure Section

The information and opinions in Morgan Stanley Research were prepared or are disseminated by Morgan Stanley Asia Limited (which accepts the responsibility for its contents) and/or Morgan Stanley Asia (Singapore) Pte. (Registration number 199206298Z) and/or Morgan Stanley Asia (Singapore) Securities Pte Ltd (Registration number 200008434H), regulated by the Monetary Authority of Singapore (which accepts legal responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research), and/or Morgan Stanley Taiwan Limited and/or Morgan Stanley & Co International plc, Seoul Branch, and/or Morgan Stanley Australia Limited (A.B.N. 67 003 734 576, holder of Australian financial services license No. 233742, which accepts responsibility for its contents), and/or Morgan Stanley Wealth Management Australia Pty Ltd (A.B.N. 19 009 145 555, holder of Australian financial services license No. 240813, which accepts responsibility for its contents), and/or Morgan Stanley India Company Private Limited having Corporate Identification No (CIN) U22990MH1998PTC115305, regulated by the Securities and Exchange Board of India ('SEBI') and holder of licenses as a Research Analyst (SEBI Registration No. INH000001105); Stock Broker (SEBI Stock Broker Registration No. INZ000244438), Merchant Banker (SEBI Registration No. INM000011203), and depository participant with National Securities Depository Limited (SEBI Registration No. IN-DP-NSDL-567-2021) having registered office at Altimus, Level 39 & 40, Pandurang Budhkar Marg, Worli, Mumbai 400018, India; Telephone no. +91-22-61181000; Compliance Officer Details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: tejarshi.hardas@morganstanley.com; Grievance officer details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: msic-compliance@morganstanley.com which accepts the responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research, and their affiliates (collectively, "Morgan Stanley"). Morgan Stanley India Company Private Limited (MSICPL) may use AI tools in providing research services. All recommendations contained herein are made by the duly qualified research analysts.

For important disclosures, stock price charts and equity rating histories regarding companies that are the subject of this report, please see the Morgan Stanley Research Disclosure Website at www.morganstanley.com/eqr/disclosures/webapp/generalresearch, or contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY, 10036 USA.

For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US/Canada +1 800 303-2495; Hong Kong +852 2848-5999; Latin America +1 718 754-5444 (U.S.); London +44 (0)20-7425-8169; Singapore +65 6834-6860; Sydney +61 (0)2-9770-1505; Tokyo +81 (0)3-6836-9000. Alternatively you may contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY 10036 USA.